The United States will remove strong safety warnings on many hormone therapies used to alleviate menopausal symptoms, saying the risks have been exaggerated, authorities announced Monday.

Hormone Replacement Therapy (HRT) replaces estrogen that the female body stops producing during menopause with the aim of alleviating symptoms including hot flashes, brain fog, insomnia, night sweats and joint pain.

Previously used routinely, prescription and use of the therapies have plummeted worldwide since a landmark trial in the early 2000s pointed to risks associated with specific HRT formulations.

Since then "black box warnings" -- the strongest warning the US Food and Drug Administration can require on prescription drugs -- have sounded alarm over increased HRT risks including of certain cancer

See Full Page